Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26714240 | 0.84 | HNF4A (0.43) | LMNAMEN1KMT2AALDH1A1MAPT | |
| SCHEMBL26714232 | 0.82 | HPGD (0.44) | SMN1; SMN2ALDH1A1 | |
| SCHEMBL26714243 | 0.81 | GAA (0.37) | TDP1MEN1KMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL7168763 | 0.81 | HIF1A (0.59) | HIF1AFFAR1 | |
| SCHEMBL7168758 | 0.81 | HIF1A (0.59) | HIF1AFFAR1 | |
| SCHEMBL9215653 | 0.80 | FFAR1 (0.47) | MEN1KMT2ASMN1; SMN2FFAR1 | |
| SCHEMBL26714172 | 0.80 | NPC1 (0.45) | LMNASMN1; SMN2 | |
| SCHEMBL30593675 | 0.80 | CYP4F2 (0.42) | MEN1KMT2ASMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL23712566 | 0.80 | FOLH1 (0.35) | MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL9148399 | 0.80 | FFAR1 (0.50) | HIF1AFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230354808-A1 | METHOD OF CONTROLLING SOYBEAN RUST FUNGUS RESISTANT TO QOI FUNGICIDE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-11-09 | — | — | US | disclosed |
| US-20230354808-A1 | METHOD OF CONTROLLING SOYBEAN RUST FUNGUS RESISTANT TO QOI FUNGICIDE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-11-09 | — | — | US | disclosed |
| WO-2021153794-A1 | METHOD OF CONTROLLING SOYBEAN RUST FUNGUS RESISTANT TO QOI FUNGICIDE | 住友化学株式会社 | 2021-08-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230354808-A1 | METHOD OF CONTROLLING SOYBEAN RUST FUNGUS RESISTANT TO QOI FUNGICIDE | SQOR, CYC1, COX5B | LMNA 2839/4885CTDSP1 3495/4885TDP1 4430/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.